AzTrials
AzTrials

HydrationNCT07005895

Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes

An observational study of Hydration, run by PepsiCo Global R&D at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This remote study will evaluate the feasibility of using the Gatorade Sports Science Institute (GSSI) Labs App for remotely collecting hydration related outcomes. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Hydration
What is being tested?
Hydration assessment via mobile app
How many people
200 participants
Where
1 siteUnited States
Study dates
6 May 2025to 30 Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Activity tracker-wearing adult

Who may be able to join

  • 18-65 years of age, inclusive
  • Male or female. If female, subject is not pregnant, planning to get pregnant, or currently breast feeding
  • Able to speak, write, and read English
  • Provision of written consent to participate
  • Owns and wears an activity tracker daily, including during sleep, except when submerged underwater (i.e., swimming, bathing) and is willing to connect their device to the app, per GSSI Labs App requirements (Oura, WHOOP, Apple Watch, Garmin, Polar, Withings, or Fitbit).
  • Owns a bathroom scale
  • Able to drink 600mL (600 mL = 20 oz = 2 ½ cups) of water as directed.
  • Willing to avoid alcohol consumption 24 hours prior to study session(s)

Who cannot join

  • Subject is currently enrolled in a clinical trial or has participated in a clinical trial within the past 30 days.
  • Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Shellen Goltz, PhD, RD contact

312-821-3317

Shellen.Goltz@pepsico.com

United States1 site, 1 recruiting
  • Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences

    Chicago, Illinois, 60607

    Shellen Goltz: Do not contact to participate, PhD, RD

    Recruiting

Other trials in United States

About this study

Official title: Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes: User Engagement and Individual Variability of Transdermal Optical Imaging Features Before and After Acute Fluid Ingestion

This remote study will evaluate the feasibility of using the Gatorade Sports Science Institute (GSSI) Labs App for remotely collecting hydration related outcomes.

Read the detailed description

The primary objective is to understand user engagement and feasibility of remotely collecting subjective and self-reported markers of hydration status as well as markers of hydration using transdermal optical imaging (TOI) within the Gatorade Sports Science Institute (GSSI) branded mobile application (adherence and dropout rates, and differences between demographics). The secondary objective is to understand the within subject variability of TOI features before and after acute fluid ingestion during remote data collection.

Tertiary objectives are to compare self-reported measures of hydration status against the TOI hydration model prediction before and after acute fluid ingestion during remote data collection.

An outside service was contracted for recruiting. Please do not contact the investigator to express interest.

Conditions
Hydration
Being tested
Hydration assessment via mobile app
Keywords
transdermal optical imaging, TOI, app, user engagement
Medical subject headings
Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hydration assessment via mobile appOther

    Open the Gatorade Sports Science Institute (GSSI) branded mobile application and click on 'Complete Hydration Assessment'

Study groups in NCT07005895
Study groupRoleWhat they receive
Healthy adult user of a wearable activity trackerMale or female 18-65 who wears their own activity tracker daily
Receives: Other: Hydration assessment via mobile app

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. User engagement and feasibility: Subjective and self-reported markers of hydration status

    Understand user engagement and feasibility of remotely collecting subjective and self-reported markers of hydration status

    Measured: At two identical 2-hour study sessions with at least one full day and a maximum of 6 days in between study sessions

  2. User engagement and feasibility: Markers of hydration using transdermal optical imaging (TOI)

    Understand user engagement and feasibility of remotely collecting markers of hydration using transdermal optical imaging (TOI)

    Measured: At two identical 2-hour study sessions with at least one full day and a maximum of 6 days in between study sessions

Secondary outcomes (1)
  1. Understand the within subject variability of TOI features before and after acute fluid ingestion during remote data collection

    Within subject variation in the tertiary outcomes listed in Other Pre-specified Outcomes 4-7

    Measured: At two identical 2-hour study sessions with at least one full day and a maximum of 6 days in between study sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2025
  2. Study start6 May 2025
  3. Primary completion30 Dec 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07005895
Sponsor's protocol ID
PEP-2503
Status last verified
May 2025
First submitted
12 May 2025
Last updated
5 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hydration, run by PepsiCo Global R&D at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shellen Goltz, PhD, RD (312-821-3317, Shellen.Goltz@pepsico.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

User engagement and feasibility: Subjective and self-reported markers of hydration status (time frame: At two identical 2-hour study sessions with at least one full day and a maximum of 6 days in between study sessions). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in